These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8948266)

  • 1. Cholesterol-lowering and coronary atherosclerosis: good news and bad news.
    Kreisberg RA
    Am J Med; 1996 Nov; 101(5):455-8. PubMed ID: 8948266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol synthesis inhibitors. Clinical studies on lowering coronary risk and plaque stabilization].
    Müller-Wieland D; Faust M; Krone W
    Internist (Berl); 1998 Sep; 39(9):934-42. PubMed ID: 9788115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholesterol and coronary sclerosis].
    Immich H
    Versicherungsmedizin; 1997 Jun; 49(3):86-8. PubMed ID: 9273772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on HDL as a therapeutic target for CAD risk reduction.
    Davidson MH
    Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of atherosclerosis in coronary-artery bypass grafts.
    Fuster V; Vorchheimer DA
    N Engl J Med; 1997 Jan; 336(3):212-3. PubMed ID: 8988902
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipidemia in older adults.
    Aslam F; Haque A; Lee LV; Foody J
    Clin Geriatr Med; 2009 Nov; 25(4):591-606, vii. PubMed ID: 19944263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goals for cholesterol lowering.
    Stankler L
    Circulation; 1999 May; 99(18):2477. PubMed ID: 10318741
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum cholesterol levels are underevaluated and undertreated.
    Danias PG; O'Mahony S; Radford MJ; Korman L; Silverman DI
    Am J Cardiol; 1998 Jun; 81(11):1353-6. PubMed ID: 9631975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.
    Myerson M; Rosenson RS
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):203-4. PubMed ID: 24610170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Moderate hypercholesterolemia and coronary disease: the MAAS study and the 4S study].
    Martinez C; Legrand V; Kulbertus H
    Rev Med Liege; 1995 Jan; 50(1):35-40. PubMed ID: 7871285
    [No Abstract]   [Full Text] [Related]  

  • 12. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol, cholesterol lowering, and endothelial function.
    Vogel RA; Corretti MC; Gellman J
    Prog Cardiovasc Dis; 1998; 41(2):117-36. PubMed ID: 9790413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of cholesterol-lowering in patients after coronary artery bypass surgery].
    von Hodenberg E; Breidenbach T; Melichercik J
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i78-82. PubMed ID: 16598555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAD-prevention--a perspective.
    Maisch B; Shepherd J
    Herz; 1999 Feb; 24(1):1-2. PubMed ID: 10093007
    [No Abstract]   [Full Text] [Related]  

  • 18. Lessons learned from recent lipid-lowering trials: why physicians should change clinical practice.
    Watson KE; Fonarow GC
    Clin Cornerstone; 2003; Suppl 1():S11-7. PubMed ID: 14699987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    Post Coronary Artery Bypass Graft Trial Investigators
    N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ
    N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.